Alphabet as of June 30, 2023
Portfolio Holdings for Alphabet
Alphabet holds 47 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
UiPath Cl A (PATH) | 12.5 | $233M | 14M | 16.57 | |
Verve Therapeutics (VERV) | 10.6 | $198M | 11M | 18.75 | |
Oscar Health Cl A (OSCR) | 10.4 | $194M | 24M | 8.06 | |
Crowdstrike Hldgs Cl A (CRWD) | 10.1 | $189M | 1.3M | 146.87 | |
Prime Medicine (PRME) | 9.3 | $174M | 12M | 14.65 | |
Dex (DXCM) | 8.4 | $156M | 1.2M | 128.51 | |
Gitlab Class A Com (GTLB) | 7.3 | $135M | 2.6M | 51.11 | |
Planet Labs Com Cl A (PL) | 5.5 | $103M | 32M | 3.22 | |
Snowflake Cl A (SNOW) | 5.1 | $94M | 536k | 175.98 | |
Eqrx | 4.8 | $89M | 48M | 1.86 | |
Freshworks Class A Com (FRSH) | 3.8 | $71M | 4.0M | 17.58 | |
Lyft Cl A Com (LYFT) | 1.9 | $36M | 3.7M | 9.59 | |
Benson Hill Common Stock (BHIL) | 1.1 | $20M | 15M | 1.30 | |
Relay Therapeutics (RLAY) | 1.1 | $20M | 1.6M | 12.56 | |
Desktop Metal Com Cl A (DM) | 1.1 | $20M | 11M | 1.77 | |
Lyell Immunopharma (LYEL) | 1.0 | $19M | 5.9M | 3.18 | |
Sana Biotechnology (SANA) | 0.9 | $17M | 2.8M | 5.96 | |
Beam Therapeutics (BEAM) | 0.6 | $10M | 322k | 31.93 | |
Rapt Therapeutics (RAPT) | 0.5 | $10M | 540k | 18.70 | |
Monte Rosa Therapeutics (GLUE) | 0.5 | $10M | 1.5M | 6.85 | |
Illumina (ILMN) | 0.5 | $10M | 54k | 187.49 | |
Decibel Therapeutics | 0.3 | $6.3M | 1.6M | 3.85 | |
Robinhood Mkts Com Cl A (HOOD) | 0.3 | $6.1M | 612k | 9.98 | |
Adagio Therapeutics (IVVD) | 0.3 | $6.0M | 5.7M | 1.05 | |
Tenaya Therapeutics (TNYA) | 0.3 | $5.4M | 916k | 5.87 | |
Vera Therapeutics Cl A (VERA) | 0.3 | $4.8M | 302k | 16.05 | |
Foghorn Therapeutics (FHTX) | 0.2 | $3.5M | 501k | 7.04 | |
Vaccitech Ads (BRNS) | 0.2 | $3.1M | 1.5M | 2.06 | |
Tscan Therapeutics (TCRX) | 0.1 | $2.7M | 1.1M | 2.50 | |
Magenta Therapeutics | 0.1 | $2.5M | 3.3M | 0.76 | |
Kronos Bio (KRON) | 0.1 | $2.5M | 1.4M | 1.72 | |
EXACT Sciences Corporation (EXAS) | 0.1 | $2.2M | 23k | 93.90 | |
Hyperfine Com Cl A (HYPR) | 0.1 | $1.9M | 899k | 2.15 | |
Rani Therapeutics Hldgs Com Cl A (RANI) | 0.1 | $1.8M | 449k | 4.12 | |
Autolus Therapeutics Spon Adr (AUTL) | 0.1 | $1.7M | 698k | 2.38 | |
Spero Therapeutics (SPRO) | 0.1 | $1.3M | 890k | 1.45 | |
Alector (ALEC) | 0.1 | $1.1M | 176k | 6.01 | |
Science 37 Holdings | 0.0 | $674k | 3.2M | 0.21 | |
Oportun Finl Corp (OPRT) | 0.0 | $566k | 95k | 5.97 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.0 | $423k | 641k | 0.66 | |
Cortexyme (QNCX) | 0.0 | $286k | 189k | 1.51 | |
Invitae (NVTAQ) | 0.0 | $266k | 236k | 1.13 | |
Evelo Biosciences Com New (EVLO) | 0.0 | $172k | 53k | 3.25 | |
Mondee Holdings Class A Com (MOND) | 0.0 | $164k | 18k | 8.91 | |
Repligen Corporation (RGEN) | 0.0 | $54k | 383.00 | 141.46 | |
Fulcrum Therapeutics (FULC) | 0.0 | $47k | 14k | 3.30 | |
Cue Health (HLTH) | 0.0 | $10k | 27k | 0.37 |